Next Article in Journal
Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan
Previous Article in Journal
Comparative Effectiveness of Various Multi-Antigen Vaccines in Controlling Campylobacter jejuni in Broiler Chickens
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 12
Issue 8
10.3390/vaccines12080909
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Vaccines 2022, 10(10), 1668.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668

by
Hannah Murphy
and
Hinh Ly
*
Comparative & Molecular Biosciences Graduate Program, Department of Veterinary & Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Twin Cities, St. Paul, MN 55108, USA
*
Author to whom correspondence should be addressed.
Vaccines 2024, 12(8), 909; https://doi.org/10.3390/vaccines12080909
Submission received: 2 July 2024 / Accepted: 6 August 2024 / Published: 12 August 2024
Versions Notes
The authors would like to make the following corrections to this published paper [1].
In the original publication [1], there was a mistake in the first column of Table 1, published as “INO-4500 (MV backbone)”. The corrected notation for this should be “INO-4500 (DNA-based vaccine)”.
There was an error in a sentence in the first paragraph of Section 4.1. Measles Virus Platform, published as “The INO-4500 is a DNA-based vaccine candidate that expresses the LASV GPC and is based on the Schwarz strain of the measles virus (MV) [94,95]”, which should be changed to the following version: “The INO-4500 is a DNA-based vaccine candidate that expresses the LASV GPC [94,95]”. The first sentence in the second paragraph of Section 4.1, “In addition to INO-4500, another vaccine candidate has been developed using the Schwarz MV vaccine platform, MV-LASV (V182-001, MeV-NP)”, should be removed.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Murphy, H.; Ly, H. Correction: Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668. Vaccines 2024, 12, 909. https://doi.org/10.3390/vaccines12080909

AMA Style

Murphy H, Ly H. Correction: Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668. Vaccines. 2024; 12(8):909. https://doi.org/10.3390/vaccines12080909

Chicago/Turabian Style

Murphy, Hannah, and Hinh Ly. 2024. "Correction: Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668" Vaccines 12, no. 8: 909. https://doi.org/10.3390/vaccines12080909

APA Style

Murphy, H., & Ly, H. (2024). Correction: Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668. Vaccines, 12(8), 909. https://doi.org/10.3390/vaccines12080909

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop